{"SPADE_UN_11648": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_11648", "Peptide Name": "H4", "Source": "Synthetic construct", "Family": "Derived from BMAP-27 and OP-145", "Gene": "Not found", "Sequence": "KFKKLFKKLSPVIGKEFKRIVERIKRFLR", "Sequence Length": 29, "UniProt Entry": "No entry found", "Protein Existence": "Synthetic", "Biological Activity": ["Antimicrobial", "Antibacterial", "Anti-Gram+", "Anti-Gram-"], "Target Organism": "[Ref.29910626] Gram-positive bacteria:Staphylococcus aureus ATCC 29213 (MIC=20 μM), Staphylococcus aureus ATCC 33591 (MIC=10 μM), Staphylococcus aureus ATCC 43300 (MIC=10 μM), Staphylococcus aureus ATCC BAA41 (MIC=10 μM), Enterococcus faecalis ATCC 19433 (MIC=15 μM), Enterococcus faecalis ATCC BAA2365 (MIC=5 μM), Staphylococcus epidermidis ATCC 12228 (MIC=10 μM), Enterococcus faecium ATCC BAA2316 (MIC=5 μM);Gram-negative bacteria:Escherichia coli ATCC 25922 (MIC=10 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=20 μM), Acinetobacter baumannii ATCC 19606 (MIC=10 μM), Klebsiella pneumoniae ATCC 13883 (MIC=2.5 μM), Pseudomonas aeruginosa ATCC BAA2114 (MIC=25 μM), Escherichia coli ATCC BAA2452 (MIC=10 μM)", "Hemolytic Activity": "[Ref.29910626] 0% haemolysis at 5 μM, 0% haemolysis at 10 μM, 0% haemolysis at 25 μM, 0% haemolysis at 40 μM, 0% haemolysis at 55 μM, 0% haemolysis at 75 μM, 0% haemolysis at 80 μM, 2.1% haemolysis at 100 μM against human red blood cells", "Cytotoxicity": "[Ref.29910626] IC50 = 61.9±0.18 μM against HEK293.IC50 = 64.9±1.01 μM against Vero.", "Binding Target": "Not found", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "The peptide adopts a conformational structure with 90 % alpha helix.", "Formula": "C174H295N49O35", "Mass": 3633.51, "PI": 11.62, "Net Charge": 10, "Hydrophobicity": -0.5, "Half Life": "Mammalian:1.3 hourYeast:3 minE.coli:2 min", "Function": "Antibacterial activity against the Gram-positive and Gram-negative bacteria.", "Literature": [{"Title": "Hybridization and antibiotic synergism as a tool for reducing the cytotoxicity of antimicrobial peptides.", "Pubmed ID": "29910626", "Reference": "Infect Drug Resist. 2018 Jun 1;11835-847.", "Author": "Almaaytah A, Qaoud MT, Abualhaijaa A, Al-Balas Q, Alzoubi KH.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=29910626"}, {"Title": "Hybridization and antibiotic synergism as a tool for reducing the cytotoxicity of antimicrobial peptides", "Pubmed ID": "", "Author": "Almaaytah A, Qaoud MT, Abualhaijaa A, Al-Balas Q, Alzoubi KH"}], "Frequent Amino Acids": "KFR", "Absent Amino Acids": "ACDHMNOQTUWY", "Basic Residues": 12, "Acidic Residues": 2, "Hydrophobic Residues": 13, "Polar Residues": 15, "Positive Residues": 12, "Negative Residues": 2, "Similar Sequences": [{"SPADE_ID": "SPADE_N_02482", "Similarity": 1.0, "Sequence": "GRFKRFRKKFKKLFKKLS"}, {"SPADE_ID": "SPADE_UN_15104", "Similarity": 1.0, "Sequence": "GRFKRFRKKFKKLFK"}, {"SPADE_ID": "SPADE_UN_15252", "Similarity": 1.0, "Sequence": "MGRFKRFRKKFKKLFKKLS"}]}}}